Mastitis Market Overview
The Mastitis Market focuses on products, treatments, diagnostic technologies, and healthcare solutions used to prevent, diagnose, and manage mastitis in both bovine and human populations. Mastitis is an inflammatory condition that can affect dairy cattle and breastfeeding women, creating demand for effective diagnostic, therapeutic, and preventive approaches. The market includes antibiotics, vaccines, pain relievers, diagnostic technologies, and other treatment solutions designed to improve disease management and outcomes.
According to MRFR analysis, the Mastitis Market was valued at USD 27.58 billion in 2024 and is projected to grow from USD 32.20 billion in 2025 to USD 151.24 billion by 2035, registering a CAGR of 16.73% during the forecast period 2025–2035. North America accounted for over 44.96% of the global market in 2024.
Get Free Sample PDF Brochure:
https://www.marketresearchfuture.com/sample_request/5379
Market Drivers
Growing Awareness of Animal Health:
Increasing awareness of animal health and welfare is encouraging dairy farmers to adopt improved mastitis prevention, diagnostic, and treatment practices. Effective mastitis management helps maintain herd health, milk quality, and dairy productivity, supporting demand for veterinary treatment solutions.
Increasing Demand for Dairy Products:
Growing global demand for dairy products is encouraging producers to maintain healthy and productive dairy herds. Mastitis can reduce milk production and affect milk quality, increasing the need for effective prevention and treatment strategies across dairy operations.
Advancements in Diagnostic Technologies:
Technological advancements are improving the early detection and management of mastitis. Rapid testing kits, digital monitoring systems, and other diagnostic technologies can help identify infections earlier and support timely treatment, contributing to market expansion.
Advancements in Treatment Technologies:
The development of targeted therapies, improved antibiotic formulations, vaccines, immunomodulators, and alternative treatment approaches is expanding the range of available mastitis management solutions. These innovations are also supporting efforts to improve treatment effectiveness and reduce reliance on conventional antibiotics.
Rising Incidence of Mastitis in Dairy Cattle:
The prevalence of mastitis among dairy cattle creates substantial demand for veterinary treatments and preventive products. Mastitis can negatively affect milk production, animal health, and farm economics, encouraging dairy producers to invest in improved management solutions.
Market Challenges
Antimicrobial Resistance Concerns:
Increasing concerns surrounding antimicrobial resistance are creating challenges for the use of antibiotics in mastitis management. Regulatory authorities and livestock producers are increasingly focusing on responsible antibiotic use and alternative treatment approaches.
High Treatment Costs:
Advanced diagnostic technologies, veterinary consultations, medicines, vaccines, and preventive management programs can increase the cost of mastitis control, particularly for smaller dairy farms and producers operating with limited resources.
Limited Veterinary Healthcare Access:
In developing and emerging regions, limited access to specialized veterinary services, diagnostic facilities, and modern treatment technologies can restrict effective mastitis diagnosis and management.
Treatment Complexity:
Mastitis can have different causes and presentations, requiring appropriate diagnosis and treatment. Differences between bovine and human mastitis also create varied requirements for therapeutic products and healthcare services.
Regulatory Requirements:
Increasing regulatory scrutiny of antibiotics, animal welfare, food safety, and milk quality can increase compliance requirements for manufacturers and dairy producers, influencing product development and market adoption.
Browse In-depth Market Research Report on Mastitis Market:
https://www.marketresearchfuture.com/reports/mastitis-market-5379
Market Segmentation
By Type:
Bovine Mastitis: Includes contagious mastitis, environmental mastitis, and opportunist mastitis affecting dairy cattle.
Human Mastitis: Includes non-infectious mastitis and infectious mastitis, particularly affecting breastfeeding women.
By Treatment:
Bovine Antibiotics: Antibiotic-based treatments used to manage bacterial mastitis infections in dairy cattle.
Bovine Vaccines: Preventive solutions designed to support disease prevention and reduce mastitis occurrence.
Human Pain Relievers: Medications used to manage pain and discomfort associated with human mastitis.
Human Antibiotics: Antibiotic treatments used for infectious mastitis when clinically appropriate.
By End User:
Veterinary Centers: Specialized facilities providing diagnosis, treatment, and prevention services for mastitis in livestock.
Hospitals & Clinics: Healthcare facilities involved in diagnosing and treating human mastitis and related conditions.
Regional Insights
North America:
North America held the largest share of the Mastitis Market, accounting for more than 44.96% of global revenue in 2024. The region benefits from advanced veterinary healthcare infrastructure, established dairy production, increasing awareness of animal health, and investments in research and development. The United States and Canada represent important markets for mastitis treatment and prevention solutions.
Europe:
Europe represented a significant portion of the global Mastitis Market, supported by established dairy farming practices and strong animal health regulations. Increasing emphasis on responsible antibiotic use and sustainable livestock management is encouraging demand for preventive solutions and alternative treatment approaches.
Asia-Pacific:
Asia-Pacific is an emerging market supported by increasing dairy consumption, expanding livestock production, growing awareness of animal health, and government initiatives focused on improving livestock productivity. India and China are important markets within the region.
Middle East & Africa:
The Middle East and Africa represent developing markets for mastitis management. Improvements in dairy production, veterinary services, and livestock health awareness are creating opportunities for treatment and prevention products, although access to veterinary infrastructure remains a challenge.
Key Players
Zoetis
Merck Animal Health
Boehringer Ingelheim
Elanco Animal Health
Cegelec
Vetoquinol
Huvepharma
Phibro Animal Health
Dechra Pharmaceuticals
Future Outlook
The Mastitis Market is expected to experience substantial growth as demand increases for advanced diagnostic technologies, preventive healthcare, and effective treatment solutions for both bovine and human mastitis. The market is projected to reach USD 151.24 billion by 2035, growing at a CAGR of 16.73% during 2025–2035.
Future market opportunities are expected to include AI-driven analytics for early disease detection, improved diagnostic technologies, non-antibiotic treatment alternatives, advanced vaccines, and sustainable livestock health management. Growing awareness of animal welfare and the need to maintain milk quality and dairy productivity are also expected to support continued market development.
Understand industry shifts with well-researched analysis:
Asia Pacific Diabetes Pen Market Trends
Regulatory Reporting and Compliance Market Growth
Norovirus Treatment Market Volume
Psilocybin Assisted Therapy Market Forecast
About Market Research Future:
Market Research Future (MRFR) is a global market research company that provides market research and consulting services across diverse industries and geographic markets. MRFR’s research covers products, services, technologies, applications, end users, and market players across global, regional, and country-level markets, helping organizations understand market trends, growth opportunities, competitive dynamics, and industry developments.
Follow Us: LinkedIn | Twitter
Contact:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com
